AWM
EW icon

Apollon Wealth Management’s Edwards Lifesciences EW Stock Holding History

Apollon Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$907K Buy
10,024
+152
+2% +$12.7K 0.01% 771
2026
Q1 		$791K Buy
9,872
+1,323
+15% +$109K 0.01% 690
2025
Q4 		$729K Sell
8,549
-494
-5% -$40.5K 0.01% 692
2025
Q3 		$703K Sell
9,043
-947
-9% -$74K 0.01% 704
2025
Q2 		$781K Buy
9,990
+2,074
+26% +$155K 0.02% 625
2025
Q1 		$574K Buy
7,916
+645
+9% +$46.2K 0.01% 692
2024
Q4 		$538K Sell
7,271
-1,187
-14% -$83.1K 0.01% 723
2024
Q3 		$558K Sell
8,458
-4,283
-34% -$311K 0.02% 670
2024
Q2 		$1.18M Sell
12,741
-8,505
-40% -$753K 0.04% 418
2024
Q1 		$2.03M Buy
21,246
+189
+0.9% +$15.9K 0.06% 286
2023
Q4 		$1.61M Buy
21,057
+3,661
+21% +$255K 0.06% 314
2023
Q3 		$1.21M Sell
17,396
-1,109
-6% -$89.1K 0.06% 311
2023
Q2 		$1.75M Buy
18,505
+6,018
+48% +$523K 0.08% 239
2023
Q1 		$1.03M Buy
12,487
+119
+1% +$9.35K 0.06% 318
2022
Q4 		$923K Buy
12,368
+459
+4% +$35.4K 0.07% 325
2022
Q3 		$984K Buy
11,909
+77
+0.7% +$7.41K 0.08% 257
2022
Q2 		$1.13M Buy
11,832
+898
+8% +$93K 0.09% 234
2022
Q1 		$1.29M Buy
10,934
+1,452
+15% +$163K 0.09% 229
2021
Q4 		$1.23M Buy
9,482
+7,343
+343% +$857K 0.09% 239
2021
Q3 		$242K Buy
2,139
+46
+2% +$5.25K 0.03% 393
2021
Q2 		$217K Buy
+2,093
New +$197K 0.04% 337
2020
Q3 		– Sell
-559
Closed -$39K – 321
2020
Q2 		$39K Buy
+559
New +$39.7K 0.02% 279

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Apollon Wealth Management's EW Position: Q2 2026 in Review

Apollon Wealth Management increased its Edwards Lifesciences (EW) stake by 1.5% in Q2 2026, buying an estimated $12.7K and bringing the position to 10,024 shares worth $907K. The position accounts for 0.01% of the portfolio, ranked #771.

Apollon Wealth Management first reported a position in EW in Q2 2020 and has held it in 22 quarters since. The position peaked at $2.03M in Q1 2024. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Apollon Wealth Management held 10,024 shares of Edwards Lifesciences worth $907K as of Q2 2026.
  • Apollon Wealth Management bought 152 Edwards Lifesciences shares in Q2 2026, an estimated $12.7K.
  • Edwards Lifesciences made up 0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #771 holding.
  • Apollon Wealth Management first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 22 quarters since.
  • Apollon Wealth Management's Edwards Lifesciences position peaked at $2.03M in Q1 2024.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.